Myriad Genetics sell JPMorgan Chase & Co.
Start price
07.11.23
/
50%
€16.70
Target price
07.11.24
€13.08
Performance (%)
2.40%
End price
08.11.24
€17.10
Summary
This prediction ended on 08.11.24 with a price of €17.10. With a performance of 2.40%, the SELL prediction by JPMorgan_Chase___Co_ for Myriad Genetics was trending in the wrong direction JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Myriad Genetics | -2.475% | -2.475% | -56.703% |
| iShares Core DAX® | -4,93 % | -11,98 % | -3,49 % |
| iShares Nasdaq 100 | -2,63 % | -2,22 % | 13,78 % |
| iShares Nikkei 225® | -4,73 % | -10,90 % | 19,71 % |
| iShares S&P 500 | -2,54 % | -3,54 % | 8,88 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at JPMorgan Chase & Co. from $17.00 to $14.00. They now have an "underweight" rating on the stock.
Ratings data for MYGN provided by MarketBeat
In the thread Trading Myriad Genetics
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten